WA
RDY icon

Wealthstream Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Wealthstream Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$297K Buy
21,258
+3,580
+20% +$51.5K 0.04% 130
2025
Q2 		$266K Buy
17,678
+6,055
+52% +$86.5K 0.04% 132
2025
Q1 		$153K Sell
11,623
-2,923
-20% -$40.3K 0.03% 152
2024
Q4 		$230K Buy
14,546
+756
+5% +$11.4K 0.04% 133
2024
Q3 		$219K Buy
13,790
+460
+3% +$7.4K 0.04% 139
2024
Q2 		$203K Buy
+13,330
New +$191K 0.07% 132

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wealthstream Advisors's RDY Position: Q3 2025 in Review

Wealthstream Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 20% in Q3 2025, buying an estimated $51.5K and bringing the position to 21,258 shares worth $297K. The position accounts for 0.04% of the portfolio, ranked #130.

Wealthstream Advisors first reported a position in RDY in Q2 2024 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

  • Wealthstream Advisors held 21,258 shares of Dr. Reddy's Laboratories worth $297K as of Q3 2025.
  • Wealthstream Advisors bought 3,580 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $51.5K.
  • Dr. Reddy's Laboratories made up 0.04% of Wealthstream Advisors's portfolio in Q3 2025, its #130 holding.
  • Wealthstream Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 6 quarters since.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Wealthstream Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.